Colombia University Medical Center (mastocytosis) — New York, New York

Colombia University Medical Center (mastocytosis) is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Colombia University Medical Center (mastocytosis) has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.

Sponsors: Deciphera Pharmaceuticals, LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colombia University Medical Center (mastocytosis)?

Colombia University Medical Center (mastocytosis) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colombia University Medical Center (mastocytosis) conducted?

Colombia University Medical Center (mastocytosis) has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.

Is Colombia University Medical Center (mastocytosis) accredited by Crixeo Health?

Colombia University Medical Center (mastocytosis) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colombia University Medical Center (mastocytosis)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.